Aqr Capital Management LLC Summit Therapeutics Inc. Transaction History
Aqr Capital Management LLC
- $71.5 Billion
- Q3 2024
A detailed history of Aqr Capital Management LLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 68,518 shares of SMMT stock, worth $1.21 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
68,518
Previous 62,114
10.31%
Holding current value
$1.21 Million
Previous $484,000
209.92%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding SMMT
# of Institutions
192Shares Held
75.8MCall Options Held
2.01MPut Options Held
2.84M-
Baker Bros. Advisors LP New York, NY24.4MShares$432 Million5.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$194 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$140 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.44MShares$96.3 Million0.01% of portfolio
-
State Street Corp Boston, MA3.47MShares$61.4 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $3.56B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...